Literature DB >> 15598890

Deletion and purification studies to elucidate the structure of the Actinobacillus actinomycetemcomitans cytolethal distending toxin.

Keitarou Saiki1, Tomoharu Gomi, Kiyoshi Konishi.   

Abstract

Cytolethal distending toxin (CDT) is one of the exotoxins produced by Actinobacillus actinomycetemcomitans, an agent of localized aggressive periodontitis. We constructed N-terminal deletion mutants of CdtA using an Escherichia coli expression system and found that ADelta19-47, with a deletion from Asn-19 to Pro-47, showed comparable CDT activity but no apparent heterogeneity of CdtA. The wild-type CDT (wtCDT) and the mutant CDT (ADelta19-47CDT) were purified to homogeneity by introducing a histidine tag into the C-terminal end of CdtB. Both purified wtCDT and purified ADelta19-47CDT showed strong CDT activity and a tripartite structure composed of CdtA (subunit A), 31 kDa CdtB (subunit B), and 18.5 kDa CdtC (subunit C) in nearly a 1:1:1 stoichiometry. Importantly, subunit A was identified as heterogeneous with three CdtA variants in wtCDT, but homogeneous in ADelta19-47CDT. Purified CDTs also showed high stability that was absolutely dependent on the presence of sucrose in the buffer. In conclusion, the region from the Asn-19 to Pro-47 of CdtA contributes to the heterogeneous production of CdtA, but is dispensable for the toxin activity. Furthermore, this study describes an effective protocol for the purification of a native rather than reconstituted CDT, and clarifies the subunit composition of the active CDT holotoxin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15598890     DOI: 10.1093/jb/mvh121

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  Variation of loop sequence alters stability of cytolethal distending toxin (CDT): crystal structure of CDT from Actinobacillus actinomycetemcomitans.

Authors:  Taro Yamada; Junichi Komoto; Keitarou Saiki; Kiyoshi Konishi; Fusao Takusagawa
Journal:  Protein Sci       Date:  2006-02       Impact factor: 6.725

2.  Cytolethal distending toxin from Aggregatibacter actinomycetemcomitans induces DNA damage, S/G2 cell cycle arrest, and caspase- independent death in a Saccharomyces cerevisiae model.

Authors:  Oranart Matangkasombut; Roongtiwa Wattanawaraporn; Keiko Tsuruda; Masaru Ohara; Motoyuki Sugai; Skorn Mongkolsuk
Journal:  Infect Immun       Date:  2009-12-07       Impact factor: 3.441

3.  CdtC-Induced Processing of Membrane-Bound CdtA Is a Crucial Step in Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Holotoxin Formation.

Authors:  Keiko Tsuruda; Oranart Matangkasombut; Masaru Ohara; Motoyuki Sugai
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

4.  Role of intrachain disulfides in the activities of the CdtA and CdtC subunits of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans.

Authors:  Linsen Cao; Alla Volgina; Jonathan Korostoff; Joseph M DiRienzo
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

5.  Characterization of point mutations in the cdtA gene of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans.

Authors:  Linsen Cao; Alla Volgina; Chuang-Ming Huang; Jonathan Korostoff; Joseph M DiRienzo
Journal:  Mol Microbiol       Date:  2005-12       Impact factor: 3.501

6.  Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces apoptosis in nonproliferating macrophages by a phosphatase-independent mechanism.

Authors:  Shira D P Rabin; Jared G Flitton; Donald R Demuth
Journal:  Infect Immun       Date:  2009-05-26       Impact factor: 3.441

Review 7.  Bacterial toxin modulation of the eukaryotic cell cycle: are all cytolethal distending toxins created equally?

Authors:  Amandeep Gargi; Michael Reno; Steven R Blanke
Journal:  Front Cell Infect Microbiol       Date:  2012-10-08       Impact factor: 5.293

8.  Mechanisms of assembly and cellular interactions for the bacterial genotoxin CDT.

Authors:  Dragana Nesic; C Erec Stebbins
Journal:  PLoS Pathog       Date:  2005-11-18       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.